Single-Dose Study of a New Formulation of BIIB061

Clinical trial NCT02521545 · COMPLETED

Trial details

NCT number: NCT02521545
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2015-07-01
Primary completion: 2015-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.